Little Green Pharma Ltd. (AU:LGP)
ASX:LGP
Want to see AU:LGP full AI Analyst Report?
LGP Stock Chart & Stats
AU$0.10
<AU$0.01(1.67%)
At close: 4:00 PM EST
AU$0.10
<AU$0.01(1.67%)
Day’s Range― - ―
52-Week RangeAU$0.09 - AU$0.15
Previous CloseN/A
Volume21.69K
Average Volume (3M)234.87K
Market Cap
AU$29.97M
Enterprise ValueAU$32.33M
Total Cash (Recent Filing)AU$1.42M
Total Debt (Recent Filing)AU$4.69M
Price to Earnings (P/E)―
Beta0.91
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding305,855,900
10 Day Avg. Volume223,605
30 Day Avg. Volume234,865
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)0.36
Price to Sales (P/S)0.70
P/FCF Ratio-37.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA low debt load relative to equity provides durable financial flexibility: it reduces refinancing risk, preserves capacity to fund capital spending in cultivation and manufacturing, and gives the company time to reach sustained operational breakeven without forced dilution or distress financing.
Vertical Integration And Regulated ChannelsControl across cultivation, processing and finished-product manufacturing plus regulated pharmacy distribution supports quality (GMP), stable market access and margins over time. Vertical integration helps protect supply reliability, improves cost control, and strengthens competitive positioning in compliant medical markets.
Historical Revenue Scale-upA multi-year scale-up demonstrates the firm's ability to expand production, enter markets and build distribution relationships. That capacity to grow topline materially suggests durable operational expertise and a platform to leverage fixed costs as volumes recover, supporting long-term margin improvement potential.
Bears Say
Inconsistent ProfitabilityRepeated swings between profit and loss indicate the business has not yet converted revenue scale into reliable operating profitability. Persistent volatility undermines reinvestment planning, complicates long-term budgeting, and raises execution risk if margins remain sensitive to mix or one-off items.
Negative Free Cash FlowOngoing negative free cash flow means the company still depends on external financing or equity to fund growth and operations. Even modest sustained cash deficits can dilute shareholders or restrict capital allocation for capacity upgrades, hindering the firm's ability to fully capitalize on market opportunities.
Recent Revenue DeclineA meaningful year-over-year revenue pullback signals underlying demand, pricing or mix pressures. If this reflects structural reimbursement or competitive shifts, it weakens operating leverage, pressures margins and makes achieving consistent profitability more difficult absent clear market or product strategy changes.
Little Green Pharma Ltd. News
LGP FAQ
What was Little Green Pharma Ltd.’s price range in the past 12 months?
Little Green Pharma Ltd. lowest share price was AU$0.09 and its highest was AU$0.14 in the past 12 months.
What is Little Green Pharma Ltd.’s market cap?
Little Green Pharma Ltd.’s market cap is AU$29.97M.
When is Little Green Pharma Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Little Green Pharma Ltd.’s earnings last quarter?
Currently, no data Available
Is Little Green Pharma Ltd. overvalued?
According to Wall Street analysts Little Green Pharma Ltd.’s price is currently Overvalued.
Does Little Green Pharma Ltd. pay dividends?
Little Green Pharma Ltd. does not currently pay dividends.
What is Little Green Pharma Ltd.’s EPS estimate?
Little Green Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Little Green Pharma Ltd. have?
Little Green Pharma Ltd. has 305,855,900 shares outstanding.
What happened to Little Green Pharma Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Little Green Pharma Ltd.?
Currently, no hedge funds are holding shares in AU:LGP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Little Green Pharma Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:LGP Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.73%
12-Months-Change
Fundamentals
Return on Equity
10.83%
Trailing 12-Months
Asset Growth
-2.46%
Trailing 12-Months
Company Description
Little Green Pharma Ltd.
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. It offers cannabis flower medicines, cannabis extracts, tinctures, and APIs. The company was incorporated in 2016 and is headquartered in West Perth, Australia.
Technical Analysis
Cann Group
―
Epsilon Healthcare Limited
―
―
IDT Australia Limited
―
Cronos Australia Ltd.
―
Options Prices
Currently, No data available
---